Haemonetics Corporation (HAE)

Return on assets (ROA)

		Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Net income	US$ in thousands	117,558	115,401	43,375	79,469	76,526
Total assets	US$ in thousands	2,195,590	1,934,820	1,859,730	1,819,920	1,267,110
ROA		5.35%	5.96%	2.33%	4.37%	6.04%

March 31, 2024 calculation

ROA = Net income ÷ Total assets
= $117,558K ÷ $2,195,590K
= 5.35%

Haemonetics Corporation's return on assets (ROA) has shown some fluctuations over the past five years. In the most recent period ending on March 31, 2024, the company's ROA was 5.35%, slightly lower compared to the previous year. This indicates that the company generated 5.35 cents of profit for every dollar of assets it had during the period.

Looking back, the ROA was relatively consistent in the range of 4% to 6% from 2020 to 2023. However, there was a significant improvement in 2020 when the ROA reached 6.04%. This suggests that the company was able to utilize its assets more efficiently to generate profits during that year.

On the other hand, the ROA dropped to 2.33% in 2022, indicating a temporary decrease in asset efficiency. The subsequent recovery to 4.37% in 2021 shows that the company managed to improve its asset utilization.

Overall, Haemonetics Corporation's ROA performance has been generally stable over the five-year period, with some fluctuations. It is essential for stakeholders to monitor this ratio to assess the company's ability to generate profits from its assets and make informed investment decisions.